The costs and consequences of multiple sclerosis relapses: A managed care perspective
| Autor: | Thomas J. Morrow |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Disease Indirect costs Multiple Sclerosis Relapsing-Remitting Recurrence medicine Humans Immunologic Factors Disease management (health) Intensive care medicine Insurance Health Data collection business.industry Multiple sclerosis Managed Care Programs Perspective (graphical) Disease Management Health Care Costs medicine.disease Neurology Specialty pharmacy Disease Progression Physical therapy Managed care Neurology (clinical) Health Expenditures business |
| Zdroj: | Journal of the Neurological Sciences. 256:S39-S44 |
| ISSN: | 0022-510X |
| DOI: | 10.1016/j.jns.2007.01.063 |
| Popis: | One of the more common "rare diseases," multiple sclerosis (MS) offers a prototype to managed care for a unique and cost-effective model to better manage the outcomes of this dreaded disease. Using a specialty pharmacy model, the application of traditional disease management processes, including monthly contact, selected clinical assessments combined with targeted interventions, and data collection and analysis, hold the promise to significantly lower the relapse rate and disability progression for patients with MS. At the same time, savings in both direct and indirect costs should occur. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect